Filter By Category
Archives
Share on -
AXELOPRAN
Generic Name: AXELOPRAN
ABSTRACT -
Axelopran is an oral small-molecule, peripherally restricted opioid receptor antagonist developed for opioid-induced constipation and later investigated for opioid-related effects in oncology. Its molecular formula is C₂₆H₃₉N₃O₄, with molecular weight approximately 457.62 g/mol. The chemical representation above shows the 2D skeletal structure.
This document is for structured API information only. It is not a prescribing guide. Clinical use, if any, must follow the approved local label, trial protocol, and specialist medical supervision.
DOSAGE-
- Dosage should be determined only by a qualified healthcare professional or clinical-trial protocol.
- Use only according to an approved label or research protocol for the specific indication.
- Dose, duration, and monitoring may differ by opioid exposure, bowel function, cancer status, and tolerability.
- Do not start, stop, or combine with opioid therapy without medical supervision.
SIDE EFFECTS-
Possible side effects and safety concerns include:
- Abdominal pain, cramping, diarrhea, nausea, vomiting, flatulence, or altered bowel habits
- Headache, fatigue, dizziness, or malaise
- Possible opioid withdrawal-like symptoms, although peripherally restricted agents are designed to limit central effects
- Dehydration or electrolyte imbalance may occur if diarrhea is severe
- Cancer-related gastrointestinal symptoms may overlap with drug effects
ALLERGIC REACTIONS -
Hypersensitivity to Axelopran or related compounds/products may occur. Symptoms may include:
- Immediate urticaria, itching, flushing, or generalized rash
- Facial, lip, tongue, or throat swelling
- Wheezing, chest tightness, or breathing difficulty
- Dizziness, fainting, severe hypotension, or collapse
- Anaphylaxis, although uncommon, requires emergency medical treatment
Important: Patients who develop an allergic reaction to Axelopran should seek immediate medical attention and inform all future healthcare providers of the allergy.
DRUG INTERACTIONS-
Axelopran may interact with certain medicines, biologics, vaccines, protocols, or clinical conditions. Caution is needed with:
- Opioid analgesics are pharmacologic targets and require careful coordination to avoid withdrawal or pain-control problems.
- Other laxatives, antidiarrheals, or gastrointestinal motility agents may have additive effects.
- CYP/transporter-modifying medicines should be reviewed where relevant to the formulation used.
- Patients should report all opioid, pain, bowel, supplement, and herbal products.
Patients should inform healthcare providers about all prescription medicines, over-the-counter medicines, herbal products, vaccines, and supplements they are using.
PREAUTIONS–
- Assess bowel obstruction risk, severe abdominal pain, inflammatory bowel disease, and recent gastrointestinal surgery before use.
- Monitor bowel frequency, hydration, abdominal symptoms, and pain control.
- Use caution in patients with severe hepatic or renal impairment unless protocol supports use.
- Pregnancy and lactation require individualized medical review.
WARNINGS –
- Severe or persistent abdominal pain may indicate bowel obstruction or perforation and requires urgent evaluation.
- Rapid reversal of peripheral opioid effects may cause diarrhea or withdrawal-like symptoms.
- Use only under medical supervision, especially in cancer or chronic opioid-treated patients.
- Keep out of reach of children.
Share on -
. Developed by